Monthly Archives: mayo 2015

FEIOMM convoca 5 BECAS para la presentación de trabajos científicos en ASBMR 2015 Annual Meeting (American Society for Bone and Mineral Research) que se celebrará en Seattle, Washington (USA) del 9 al 12 de octubre de 2015.   Tienes hasta el jueves 9 de julio para enviar la solicitud.   Descarga aqui las BASES DE LA […]

FEIOMM convoca 5 BECAS para la presentación de trabajos científicos en ASBMR 2015 Annual Meeting (American Society for Bone and Mineral Research) que se celebrará en Seattle, Washington (USA) del 9 al 12 de octubre de 2015.FEIOMM convoca 5 BECAS para la presentación de trabajos científicos en ASBMR 2015 Annual Meeting (American Society for Bone […]

Prescribed medicines and potentially inappropriate medicines (PIM) and potentially prescribing omissions (PPO) prevalence were high among patients 85 years and over. Benzodiazepine use in those who are prone to falls and omission of calcium and vitamin D in those with osteoporosis were the most frequent PIM and PPO, respectively. Factors associated with PIM and PPO […]

J Bone Miner Res. 2015 May;30(5):934-44. doi: 10.1002/jbmr.2442. The results suggest almost all patients who have received six annual ZOL infusions can stop medication for up to 3 years with apparent maintenance of benefits. Autor: Black DM, Reid IR, Cauley JA, Cosman F, Leung PC, Lakatos P, Lippuner K, Cummings SR, Hue TF, Mukhopadhyay A, […]

J Bone Miner Res. 2015 May;30(5):929-33. doi: 10.1002/jbmr.2410. We conclude that the effects of bisphosphonates on fracture prevention in osteogenesis imperfecta are inconclusive. Adequately powered trials with a fracture endpoint are needed to further investigate the risks and benefits of bisphosphonates in this condition. Autor: Hald JD, Evangelou E, Langdahl BL, Ralston SH.